-+ 0.00%
-+ 0.00%
-+ 0.00%

J&J: JNJ-5939 WAS WELL TOLERATED IN PHASE 2B DUPLEX-AD PROOF-OF-CONCEPT STUDY

路透·12/26/2025 13:03:36

登录查看新闻详情